The Future of Metabolomics: Building competitive advantage in drug discovery

Metabolomics - the new ‘omics’ - is a dynamic and emerging field, joining genomics, transcriptomics and proteomics in enabling an integrative systems biology approach to drug discovery and development. Although metabolomics is still at an early evolutionary stage it is forecast that over the next decade the biopharma industry will apply this technology more widely in drug development and data obtained will be used in drug filing and optimizing the lifecycle management of marketed drugs.

The Future of Metabolomics provides detailed insight into the effective use of metabolomics throughout drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics. Use up-to-date case studies to understand current and future directions in the application of metabolomics to drug discovery and development, explore potential cost savings, and recognize lucrative partnering opportunities in this fast moving field.
Table of Contents
Table of Contents (PDF)
Price: $2,875.00 / GBP1,437.50